Can Offspring distunguish my antibody from a competitors?

Absolutely. In a crowded therapeutic landscape, proving your molecule is superior is critical, and we provide the platform to do just that. Our Competitive Benchmarking module is more than just a standard antibody validation for clinical trials; it's a direct interrogation of your drug's performance against its rivals.

By co-staining for your antibody and a competitor's in the same FFPE tissues in adjacent tissue sections or in a dual setting in the same tissue section, we eliminate biological variability and generate irrefutable visual evidence of performance. This side-by-side analysis, often using double-staining IHC services, allows for a direct and unambiguous comparison of specificity, binding affinity, and off-target effects in a true biological context and is ideal for demonstrating differentiated subcellular localization, proving higher specificity, or exposing potential off-target toxicity in human tissue that your competitors may have missed, giving you the confidence and data to claim 'Best-in-Class.' The process generates the powerful, decision-grade data needed to prove superior performance and secure a competitive advantage.